Post-marketing Surveillance of Annual Influenza Vaccines: Extended Vaccine Safety and Immunogenicity Evaluation.
Withdrawn prior to enrolment
Phase of Trial: Phase I
Latest Information Update: 09 Dec 2009
At a glance
- Drugs GSK 1536489A (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions; Pharmacodynamics
- 24 Oct 2009 Status changed from active, no longer recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 25 Sep 2009 Status changed from recruiting to active, no longer recruiting Last checked against ClinicalTrials.gov record.
- 06 Sep 2009 New trial record